Helsinn announces publication of anamorelin ROMANA 1 and ROMANA 2 Phase III studies in The Lancet Oncology 29 Febbraio 2016
HELSINN GROUP SIGNS EXCLUSIVE AGREEMENT WITH MUNDIPHARMA FOR THE DISTRIBUTION AND LICENCE OF ANAMORELIN IN NORTHERN EUROPE COUNTRIES 19 Febbraio 2016
Linkedin